buy medicine online indiamedicine online

    Montelukast + Levocetirizine + Acebrophylline

    Information about Montelukast + Levocetirizine + Acebrophylline

    Montelukast + levocetirizine + acebrophylline uses

    Montelukast+Levocetirizine+Acebrophylline is used in asthma prevention.

    How montelukast + levocetirizine + acebrophylline works

    Montelukast + levocetirizine + acebrophylline is a combination of three medicines: Montelukast, levocetirizine and acebrophylline which decrease the frequency of asthma attacks and relieve the symptoms of allergies associated with mucus (phlegm). Montelukast is a leukotriene antagonist. It works by blocking the action of leukotriene, a chemical messenger. This reduces inflammation in the airways and nose, and improves your symptoms. Levocetirizine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Acebrophylline is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out.

    Common side effects of montelukast + levocetirizine + acebrophylline

    Nausea, Vomiting, Diarrhoea, Abdominal upset, Skin rash, Flu-like symptoms, Dry mouth, Headache, Fatigue, Sleepiness, Rash, Urticaria, Itching, Breathing difficulty, Increased white blood cell count

    Available Medicine for Montelukast + Levocetirizine + Acebrophylline

    • ₹144
      Koye Pharmaceuticals Pvt ltd
      1 variant(s)
    • ₹160
      Fourrts India Laboratories Pvt Ltd
      1 variant(s)
    • ₹165
      Macleods Pharmaceuticals Pvt Ltd
      1 variant(s)
    • ₹210
      Saffron Therapeutics Pvt Ltd
      1 variant(s)
    • ₹150
      Zydus Cadila
      1 variant(s)
    • ₹150
      Dr. Johns Laboratories Pvt Ltd
      1 variant(s)
    • ₹220
      Globus Remedies Ltd
      1 variant(s)
    • ₹158
      Ronyd Healthcare Pvt Ltd
      1 variant(s)
    • ₹200
      Fitwel Pharmaceuticals Private Limited
      1 variant(s)
    • ₹170
      La Renon Healthcare Pvt Ltd
      1 variant(s)

    Content on this page was last updated on 10 January, 2018, by Dr. Varun Gupta (MD Pharmacology)